Practitioners
Patients
WEBINAR
Join our live CPD webinar for GPs and primary care prescribers, exploring how pharmacogenomic (PGx) testing can support safer, more effective prescribing—especially in patients with mental health needs, multiple medications, or complex treatment responses.
On Demand
Duration: 45 mins
Audience
General Practitioners (GPs)
Clinical Pharmacists
From antidepressants and painkillers to statins and PPIs, many of the drugs prescribed daily in primary care are influenced by genetics. For patients with ongoing symptoms, unexpected side effects, or on 3+ medications, PGx testing offers critical insights that can guide safer, more effective treatment.
This webinar will provide a practical, case-based look at how PGx fits into primary care prescribing decisions—helping reduce trial-and-error and improve outcomes across a range of common conditions.
As primary care continues to manage more complex cases—especially around mental health, chronic pain, and multimorbidity—tools like PGx can play a vital role in reducing avoidable harm, improving adherence, and supporting shared decision-making with patients. With increasing NHS interest in personalised medicine, now is the time for GPs to become confident in applying PGx insights.
Chief Scientific Officer
CMO
Join our live CPD webinar for GPs and primary care prescribers, exploring how pharmacogenomic (PGx) testing can support safer, more effective prescribing—especially in patients with mental health needs, multiple medications, or complex treatment responses.